Clinical Trial Update: Study of the Effects of Pantoprazole on Levels of Prescribed Psychiatric Medications [Phase 4]

View source ↗

Summary

A Phase 4 trial investigating pantoprazole's effects on levels of prescribed psychiatric medications has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease
• Psychotic Disorders

Drugs mentioned

• Pantoprazole (pantoprazole)

Snippet

Sponsor: University of British Columbia | Conditions: Psychotic Disorders, Gastroesophageal Reflux | Phase 4 | Status: WITHDRAWN